학술논문
Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response
Document Type
Article
Author
Source
In: RMD Open . (RMD Open, 2 August 2023, 9(3))
Subject
Language
English
ISSN
20565933